No profile data available.
Aurora Cannabis Inc. (ACB) is an essential consumer products company in the marijuana product manufacturing industry, based in Edmonton, Canada.
It reported revenue of 343.29 million CAD for fiscal year 2025, up 27.0% from fiscal year 2024, and net income of 1.59 million CAD. In Q3 2026 (the quarter ended December 31, 2025) revenue was 94.19 million CAD, up 6.8% from a year before. Canada was its largest region in fiscal year 2026, with 45% of revenue. Its market capitalization was $258.55 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of December 4, 2025.
, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation.
Aurora Cannabis reported 343.29 million CAD in revenue for fiscal year 2025, up 27.0% from $270.28 million in fiscal year 2024. In Q3 2026 revenue was 94.19 million CAD.
Canada: 45% of revenue by region in fiscal year 2026, followed by Europe (41%).
$258.55 million as of December 4, 2025.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include Cronos Group Inc. (CRON), Vireo Growth Inc. (VREOF), Canopy Growth Corporation (CGC), Cresco Labs Inc. (CRLBF).